Cabunoc, Danica Fate S.
HRN: 11-94-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/17/2022
CEFUROXIME 750MG (VIAL)
05/17/2022
05/24/2022
IV
500mg
Q8h
Dengue Fever With Warning Signs; Uti
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes